Monzr Al Malki, MD and Jeffery J. Auletta, MD discuss evaluating PTCy-based GVHD prophylaxis in hematologic malignancies.
Jeffery Auletta, MD
Advertisement
Jeffery Auletta, MD, is a blood and marrow transplant physician at Nationwide Children’s Hospital.
Articles by Jeffery Auletta, MD
Jeffery Auletta, MD, discusses the impact of post-transplant cyclophosphamide in hematologic malignancies.
Advertisement
Latest Updated Articles
Drs Al Malki and Auletta on PTCy GVHD Prophylaxis in Patients With HLA-UUMDPublished: February 15th 2025 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5